Blood management in total hip arthroplasty: a nationwide trend analysis from 2011 to 2018
- PMID: 34714392
- DOI: 10.1007/s00590-021-03155-1
Blood management in total hip arthroplasty: a nationwide trend analysis from 2011 to 2018
Abstract
Purpose: With the advent of practice changes surrounding preoperative patient optimization and postoperative protocols, a marked reduction has been reported in blood transfusion rates following total hip arthroplasty (THA). Thus, the purpose of this study was to examine differences in the prevalence of preoperative anemia, thrombocytopenia, elevated international normalized ratio (INR), bleeding disorders, and pre- and postoperative blood transfusions over the last decade.
Methods: From 2011 to 2018, the American College of Surgeons National Quality Improvement Program database was queried for all primary THA procedures (n = 208,796). The following continuous variables were examined using analysis of variance: preoperative hematocrit (HCT), platelet count, and INR. The following categorical variables were analyzed by chi-squared tests: anemia (HCT < 35.5% for females and < 38.5% for males), thrombocytopenia (platelet count < 150,000/µL), INR > 2.0, bleeding disorders, preoperative transfusions, and postoperative transfusions.
Results: There were decreases in preoperative anemia (2011: 16.2%; 2018: 11.4%, p < 0.001) and postoperative transfusions (2011: high = 22.2%; 2018: low = 1.3%, p < 0.001). Statistically significant but clinically irrelevant changes were observed in preoperative HCT (2011: low = 40.3, 2018: high = 41.1, p < 0.001), platelet count (2011: low = 248,700; 2018: high = 250,100, p < 0.001), thrombocytopenia (2011: high = 4.9%; 2018: low = 4.3%, p = 0.036), INR > 2.0 (2011: high = 1.1%; 2018: low = 0.7%, p = 0.001), bleeding disorders (2011: high = 2.9%; 2018: low = 2.0%, p < 0.001), and preoperative transfusions (2011: high = 0.2%; 2018: low = 0.1%, p = 0.007).
Conclusion: Large decreases in the number of patients with preoperative anemia and those receiving postoperative blood transfusion were observed during the study period. Future investigation is needed to ascertain whether this is due to patient optimization, practice changes, "cherry-picking" of healthy patients, or a combination of these factors.
Level of evidence: III.
Keywords: Blood management; NSQIP; Total hip arthroplasty; Transfusion.
© 2021. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
References
-
- Petis S, Howard JL, Lanting BL, Vasarhelyi EM (2015) Surgical approach in primary total hip arthroplasty: anatomy, technique and clinical outcomes. Can J Surg 58:128–139. https://doi.org/10.1503/cjs.007214 - DOI
-
- Ferguson RJ, Palmer AJ, Taylor A et al (2018) Hip replacement. Lancet 392:1662–1671 - DOI
-
- Charnley J (1961) Arthroplasty of the hip. A new operation. Lancet 277:1129–1132. https://doi.org/10.1016/S0140-6736(61)92063-3 - DOI
-
- Rasouli MR, Maltenfort MG, Erkocak OF et al (2016) Blood management after total joint arthroplasty in the United States: 19-year trend analysis. Transfusion 56:1112–1120. https://doi.org/10.1111/trf.13518 - DOI
-
- Van Herck P, Vanhaecht K, Deneckere S et al (2010) Key interventions and outcomes in joint arthroplasty clinical pathways: a systematic review. J Eval Clin Pract 16:39–49 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials